Stay updated on PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Sign up to get notified when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Version v3.5.0 has been added and version v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-19T06:00:06.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T02:27:51.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the previous funding notice and Revision: v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T11:35:58.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    A site-wide notice about government funding status was added, advising users to check cc.nih.gov and opm.gov for updates. The page version was updated to Revision: v3.4.1, replacing v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-04T10:26:29.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Glossary toggle added and study-record metadata labels updated (including capitalization tweaks to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data') with Revision: v3.4.0. No core content, outcomes, or eligibility criteria were changed.
    Difference
    0.2%
    Check dated 2026-01-28T05:56:20.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:47:02.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.